Search Query :
2JJC
Hsp90 alpha atpase domain with bound small molecule fragment Deposition Author(s): Chessari, G. , Congreve, M. , Tisi, D. , Woodhead, A.J.
Date: 2008-03-31 Method: X-RAY DIFFRACTION Resolution: 1.95 Å Organism(s): Homo Sapiens Sequences Data: 2JJC_A
2VTA
Identification of n-(4-piperidinyl)-4-(2,6-dichlorobenzoylamino)-1h- pyrazole-3-carboxamide (at7519), a novel cyclin dependent kinase inhibitor using fragment-based x-ray crystallography and structure based drug design. Deposition Author(s): Berdini, V. , Boulstridge, J.A. , Carr, M.G. , Cross, D.M. , Danillon, D. , Davis, D.J. , Devine, L.A. , Early, T.R. , Feltell, R.E. , Lewis, E.J. , Mcmenamin, R.L. , Navarro, E.F. , O'Brien, M.A. , O'Reilly, M. , Reule, M. , Saxty, G. , Seavers, L.C.A. , Smith, D. , Squires, M.S. , Trewartha, G. , Walker, M.T. , Woodhead, A.J. , Woolford, A.J. , Wyatt, P.G.
Date: 2008-05-13 Method: X-RAY DIFFRACTION Resolution: 2 Å Organism(s): Homo Sapiens Sequences Data: 2VTA_A
2VTH
Identification of n-(4-piperidinyl)-4-(2,6-dichlorobenzoylamino)-1h-pyrazole-3-carboxamide (at7519), a novel cyclin dependent kinase inhibitor using fragment-based x-ray crystallography and structure based drug design Deposition Author(s): Berdini, V. , Boulstridge, J.A. , Carr, M.G. , Cross, D.M. , Danillon, D. , Davis, D.J. , Devine, L.A. , Early, T.R. , Feltell, R.E. , Lewis, E.J. , Mcmenamin, R.L. , Navarro, E.F. , O'Brien, M.A. , O'Reilly, M. , Reule, M. , Saxty, G. , Seavers, L.C.A. , Smith, D. , Squires, M.S. , Trewartha, G. , Walker, M.T. , Woodhead, A.J. , Woolford, A.J. , Wyatt, P.G.
Date: 2008-05-15 Method: X-RAY DIFFRACTION Resolution: 1.9 Å Organism(s): Homo Sapiens Sequences Data: 2VTH_A
2VTI
Identification of n-(4-piperidinyl)-4-(2,6-dichlorobenzoylamino)-1h- pyrazole-3-carboxamide (at7519), a novel cyclin dependent kinase inhibitor using fragment-based x-ray crystallography and structure based drug design. Deposition Author(s): Berdini, V. , Boulstridge, J.A. , Carr, M.G. , Cross, D.M. , Danillon, D. , Davis, D.J. , Devine, L.A. , Early, T.R. , Feltell, R.E. , Lewis, E.J. , Mcmenamin, R.L. , Navarro, E.F. , O'Brien, M.A. , O'Reilly, M. , Reule, M. , Saxty, G. , Seavers, L.C.A. , Smith, D. , Squires, M.S. , Trewartha, G. , Walker, M.T. , Woodhead, A.J. , Woolford, A.J. , Wyatt, P.G.
Date: 2008-05-15 Method: X-RAY DIFFRACTION Resolution: 2 Å Organism(s): Homo Sapiens Sequences Data: 2VTI_A
2VTJ
Identification of n-(4-piperidinyl)-4-(2,6-dichlorobenzoylamino)-1h- pyrazole-3-carboxamide (at7519), a novel cyclin dependent kinase inhibitor using fragment-based x-ray crystallography and structure based drug design Deposition Author(s): Berdini, V. , Boulstridge, J.A. , Carr, M.G. , Cross, D.M. , Danillon, D. , Davis, D.J. , Devine, L.A. , Early, T.R. , Feltell, R.E. , Lewis, E.J. , Mcmenamin, R.L. , Navarro, E.F. , O'Brien, M.A. , O'Reilly, M. , Reule, M. , Saxty, G. , Seavers, L.C.A. , Smith, D. , Squires, M.S. , Trewartha, G. , Walker, M.T. , Woodhead, A.J. , Woolford, A.J. , Wyatt, P.G.
Date: 2008-05-15 Method: X-RAY DIFFRACTION Resolution: 2.2 Å Organism(s): Homo Sapiens Sequences Data: 2VTJ_A
2VTL
Identification of n-(4-piperidinyl)-4-(2,6-dichlorobenzoylamino)-1h- pyrazole-3-carboxamide (at7519), a novel cyclin dependent kinase inhibitor using fragment-based x-ray crystallography and structure based drug design Deposition Author(s): Berdini, V. , Boulstridge, J.A. , Carr, M.G. , Cross, D.M. , Danillon, D. , Davis, D.J. , Devine, L.A. , Early, T.R. , Feltell, R.E. , Lewis, E.J. , Mcmenamin, R.L. , Navarro, E.F. , O'Brien, M.A. , O'Reilly, M. , Reule, M. , Saxty, G. , Seavers, L.C.A. , Smith, D. , Squires, M.S. , Trewartha, G. , Walker, M.T. , Woodhead, A.J. , Woolford, A.J. , Wyatt, P.G.
Date: 2008-05-15 Method: X-RAY DIFFRACTION Resolution: 2 Å Organism(s): Homo Sapiens Sequences Data: 2VTL_A
2VTM
Identification of n-(4-piperidinyl)-4-(2,6-dichlorobenzoylamino)-1h- pyrazole-3-carboxamide (at7519), a novel cyclin dependent kinase inhibitor using fragment-based x-ray crystallography and structure based drug design. Deposition Author(s): Berdini, V. , Boulstridge, J.A. , Carr, M.G. , Cross, D.M. , Danillon, D. , Davis, D.J. , Devine, L.A. , Early, T.R. , Feltell, R.E. , Lewis, E.J. , Mcmenamin, R.L. , Navarro, E.F. , O'Brien, M.A. , O'Reilly, M. , Reule, M. , Saxty, G. , Seavers, L.C.A. , Smith, D. , Squires, M.S. , Trewartha, G. , Walker, M.T. , Woodhead, A.J. , Woolford, A.J. , Wyatt, P.G.
Date: 2008-05-15 Method: X-RAY DIFFRACTION Resolution: 2.25 Å Organism(s): Homo Sapiens Sequences Data: 2VTM_A
2VTN
Identification of n-(4-piperidinyl)-4-(2,6-dichlorobenzoylamino)-1h- pyrazole-3-carboxamide (at7519), a novel cyclin dependent kinase inhibitor using fragment-based x-ray crystallography and structure based drug design. Deposition Author(s): Berdini, V. , Boulstridge, J.A. , Carr, M.G. , Cross, D.M. , Danillon, D. , Davis, D.J. , Devine, L.A. , Early, T.R. , Feltell, R.E. , Lewis, E.J. , Mcmenamin, R.L. , Navarro, E.F. , O'Brien, M.A. , O'Reilly, M. , Reule, M. , Saxty, G. , Seavers, L.C.A. , Smith, D. , Squires, M.S. , Trewartha, G. , Walker, M.T. , Woodhead, A.J. , Woolford, A.J. , Wyatt, P.G.
Date: 2008-05-15 Method: X-RAY DIFFRACTION Resolution: 2.2 Å Organism(s): Homo Sapiens Sequences Data: 2VTN_A
2VTO
Identification of n-(4-piperidinyl)-4-(2,6-dichlorobenzoylamino)-1h- pyrazole-3-carboxamide (at7519), a novel cyclin dependent kinase inhibitor using fragment-based x-ray crystallography and structure based drug design. Deposition Author(s): Berdini, V. , Boulstridge, J.A. , Carr, M.G. , Cross, D.M. , Danillon, D. , Davis, D.J. , Devine, L.A. , Early, T.R. , Feltell, R.E. , Lewis, E.J. , Mcmenamin, R.L. , Navarro, E.F. , O'Brien, M.A. , O'Reilly, M. , Reule, M. , Saxty, G. , Seavers, L.C.A. , Smith, D. , Squires, M.S. , Trewartha, G. , Walker, M.T. , Woodhead, A.J. , Woolford, A.J. , Wyatt, P.G.
Date: 2008-05-15 Method: X-RAY DIFFRACTION Resolution: 2.19 Å Organism(s): Homo Sapiens Sequences Data: 2VTO_A
2VTP
Identification of n-(4-piperidinyl)-4-(2,6-dichlorobenzoylamino)-1h- pyrazole-3-carboxamide (at7519), a novel cyclin dependent kinase inhibitor using fragment-based x-ray crystallography and structure based drug design. Deposition Author(s): Berdini, V. , Boulstridge, J.A. , Carr, M.G. , Cross, D.M. , Danillon, D. , Davis, D.J. , Devine, L.A. , Early, T.R. , Feltell, R.E. , Lewis, E.J. , Mcmenamin, R.L. , Navarro, E.F. , O'Brien, M.A. , O'Reilly, M. , Reule, M. , Saxty, G. , Seavers, L.C.A. , Smith, D. , Squires, M.S. , Trewartha, G. , Walker, M.T. , Woodhead, A.J. , Woolford, A.J. , Wyatt, P.G.
Date: 2008-05-15 Method: X-RAY DIFFRACTION Resolution: 2.15 Å Organism(s): Homo Sapiens Sequences Data: 2VTP_A